News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
705,474 Results
Type
Article (40736)
Company Profile (255)
Press Release (664483)
Multimedia
Podcasts (54)
Webinars (12)
Section
Business (205405)
Career Advice (2281)
Deals (35584)
Drug Delivery (95)
Drug Development (81359)
Employer Resources (176)
FDA (16281)
Job Trends (14962)
News (347321)
Policy (32811)
Tag
Academia (2615)
Accelerated approval (5)
Adcomms (20)
Allergies (87)
Alliances (49976)
ALS (97)
Alzheimer's disease (1393)
Antibody-drug conjugate (ADC) (134)
Approvals (16276)
Artificial intelligence (270)
Autoimmune disease (22)
Automation (17)
Bankruptcy (360)
Best Places to Work (11698)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (181)
Bladder cancer (81)
Brain cancer (27)
Breast cancer (293)
Cancer (2340)
Cardiovascular disease (180)
Career advice (1898)
Career pathing (30)
CAR-T (159)
Cell therapy (446)
Cervical cancer (20)
Clinical research (66314)
Collaboration (872)
Company closure (2)
Compensation (573)
Complete response letters (21)
COVID-19 (2611)
CRISPR (43)
C-suite (252)
Cystic fibrosis (102)
Data (2358)
Decentralized trials (2)
Denatured (19)
Depression (45)
Diabetes (277)
Diagnostics (6426)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (123)
Drug pricing (107)
Drug shortages (25)
Duchenne muscular dystrophy (98)
Earnings (87390)
Editorial (39)
Employer branding (22)
Employer resources (150)
Events (113379)
Executive appointments (751)
FDA (17678)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (783)
Gene editing (111)
Generative AI (20)
Gene therapy (326)
GLP-1 (727)
Government (4475)
Grass and pollen (4)
Guidances (169)
Healthcare (18954)
Huntington's disease (24)
IgA nephropathy (28)
Immunology and inflammation (126)
Indications (29)
Infectious disease (2757)
Inflammatory bowel disease (145)
Inflation Reduction Act (9)
Influenza (52)
Intellectual property (99)
Interviews (379)
IPO (16610)
IRA (40)
Job creations (3670)
Job search strategy (1598)
Kidney cancer (10)
Labor market (43)
Layoffs (481)
Leadership (19)
Legal (7975)
Liver cancer (76)
Lung cancer (327)
Lymphoma (159)
Machine learning (9)
Management (59)
Manufacturing (333)
MASH (79)
Medical device (13468)
Medtech (13473)
Mergers & acquisitions (19558)
Metabolic disorders (717)
Multiple sclerosis (83)
NASH (16)
Neurodegenerative disease (97)
Neuropsychiatric disorders (28)
Neuroscience (1962)
NextGen: Class of 2025 (6583)
Non-profit (4525)
Now hiring (41)
Obesity (377)
Opinion (215)
Ovarian cancer (81)
Pain (93)
Pancreatic cancer (89)
Parkinson's disease (155)
Partnered (22)
Patents (248)
Patient recruitment (118)
Peanut (47)
People (57693)
Pharmaceutical (64)
Pharmacy benefit managers (20)
Phase I (20691)
Phase II (29209)
Phase III (21725)
Pipeline (1436)
Policy (150)
Postmarket research (2571)
Preclinical (8821)
Press Release (65)
Prostate cancer (108)
Psychedelics (30)
Radiopharmaceuticals (247)
Rare diseases (389)
Real estate (5952)
Recruiting (68)
Regulatory (22503)
Reports (49)
Research institute (2363)
Resumes & cover letters (405)
Rett syndrome (6)
RNA editing (5)
RSV (43)
Schizophrenia (72)
Series A (134)
Series B (91)
Service/supplier (11)
Sickle cell disease (52)
Special edition (16)
Spinal muscular atrophy (148)
Sponsored (30)
Startups (3607)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (53)
The Weekly (33)
Vaccines (706)
Venture capitalists (42)
Weight loss (238)
Women's health (36)
Worklife (17)
Date
Today (241)
Last 7 days (914)
Last 30 days (3363)
Last 365 days (32625)
2025 (12239)
2024 (35372)
2023 (40278)
2022 (51411)
2021 (55982)
2020 (54424)
2019 (46933)
2018 (35342)
2017 (32378)
2016 (31780)
2015 (37820)
2014 (31593)
2013 (26582)
2012 (28796)
2011 (29564)
2010 (27570)
Location
Africa (751)
Alabama (54)
Alaska (7)
Arizona (233)
Arkansas (13)
Asia (38281)
Australia (6296)
California (6525)
Canada (2081)
China (542)
Colorado (278)
Connecticut (284)
Delaware (159)
Europe (82931)
Florida (966)
Georgia (217)
Idaho (58)
Illinois (553)
India (25)
Indiana (323)
Iowa (11)
Japan (175)
Kansas (107)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (935)
Massachusetts (4845)
Michigan (227)
Minnesota (406)
Mississippi (2)
Missouri (82)
Montana (27)
Nebraska (25)
Nevada (68)
New Hampshire (63)
New Jersey (1810)
New Mexico (29)
New York (1828)
North Carolina (997)
North Dakota (8)
Northern California (2884)
Ohio (213)
Oklahoma (14)
Oregon (35)
Pennsylvania (1439)
Puerto Rico (13)
Rhode Island (33)
South America (1129)
South Carolina (26)
South Dakota (1)
Southern California (2452)
Tennessee (107)
Texas (962)
United States (24351)
Utah (189)
Virginia (154)
Washington D.C. (64)
Washington State (579)
West Virginia (3)
Wisconsin (58)
705,474 Results for "applied energetics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Applied Energetics Names James Harrison, Ph.D., as Director of New Product Innovation
Applied Energetics, Inc. today announced that Dr. James Harrison has been named director of new product innovation for the company, effective April 3, 2024.
March 5, 2024
·
5 min read
Press Releases
StimCell Energetics Launches Social Media Presence
January 30, 2025
·
3 min read
Press Releases
StimCell Energetics Inc. (Formerly “Cell MedX Corp.”) Announces Major Corporate Updates and Rebranding
November 4, 2024
·
3 min read
Business
Applied Energetics Announces Appointment of Dr. Stephen W. McCahon, as Chief Science Officer
Applied Energetics, Inc., a leader in the advancement of ultrashort pulse laser, announced that Dr. Stephen W. McCahon, age 63, has been appointed as Chief Science Officer, effective May 1, 2023.
May 8, 2023
·
4 min read
Press Releases
Applied Therapeutics Reports First Quarter 2025 Financial Results
May 14, 2025
·
10 min read
Regulatory
FDA Warns Applied Therapeutics of ‘Objectionable Conditions’ in Govorestat Study
The agency’s warning letter outlines Applied Therapeutics’ failure to provide adequate information regarding the clinical trial—including a dosing error for govorestat—claims that the company said it had already addressed.
December 4, 2024
·
2 min read
·
Tristan Manalac
Drug Development
Applied Energetics Awarded $1.148 Million Phase II Small Business Technology Transfer Contract by the U.S. Army for Ultra-Broadband IRCM Source Development
Applied Energetics, Inc. announced that it has been awarded a $1.148 million Phase II Small Business Technology Transfer contract by the U.S Army to continue the Company’s research, development and testing of an ultra-broadband infrared source capable of disrupting optical infrared sensors within the engagement time window, at tactically relevant ranges.
June 5, 2023
·
3 min read
Press Releases
Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results
April 14, 2025
·
10 min read
Press Releases
Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
May 12, 2025
·
6 min read
Press Releases
Applied Pharmaceutical Innovation Appoints Dr. Launa Aspeslet as Chief Translational Officer to Accelerate Life Sciences Commercialization in Canada
May 13, 2025
·
3 min read
1 of 70,548
Next
